NCT02173652View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2008

Conditions
Healthy
Interventions
DRUG

BI 1356, high dose

DRUG

BI 1356, low dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY